EMAIL THIS PAGE TO A FRIEND

Journal of Clinical Pharmacy and Therapeutics

Genetic selection of volunteers and concomitant dose adjustment leads to comparable hydralazine/valproate exposure.


PMID 24702251

Abstract

We're sorry this abstract is currently not available.